Publications
Selected publications
- BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. (Journal article - 2023)
- The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation (Journal article - 2022)
- Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention (Journal article - 2022)
- Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. (Journal article - 2020)
- The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity (Journal article - 2018)
- Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors (Journal article - 2015)
- The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells (Journal article - 2014)
- Cellular functions of the DUBs (Journal article - 2012)
- SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer (Journal article - 2009)
- A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker (Journal article - 2000)
2024
Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.
Little, L. D., Barnett, S. E., Issitt, T., Bonsall, S., Carolan, V. A., Allen, E., . . . Haywood-Small, S. L. (2024). Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.. Journal of breath research, 18(4). doi:10.1088/1752-7163/ad7166
2023
A trafficking regulatory subnetwork governs αVβ6 Integrin-HER2 crosstalk to control breast cancer invasion and drug resistance
A trafficking regulatory subnetwork governs αVβ6 Integrin-HER2 crosstalk to control breast cancer invasion and drug resistance
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification.
Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (n.d.). BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification.. Molecular Cancer Research. doi:10.1158/1541-7786.mcr-22-0635
Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725161.v1
2022
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation
Barnett, S. E., Herrmann, A., Shaw, L., Gash, E. N., Poptani, H., Sacco, J. J., & Coulson, J. M. (2022). The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. CANCERS, 14(23). doi:10.3390/cancers14235836
Combinatorial approaches for mitigating resistance to KRAS-targeted therapies
Warren, H. R., Ross, S. J., Smith, P. D., Coulson, J. M., & Prior, I. A. (2022). Combinatorial approaches for mitigating resistance to KRAS-targeted therapies. BIOCHEMICAL JOURNAL, 479(18), 1985-1997. doi:10.1042/BCJ20220440
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention
Sabat-Pospiech, D., Fabian-Kolpanowicz, K., Kalirai, H., Kipling, N., Coupland, S. E., Coulson, J. M., & Fielding, A. B. (2022). Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 8(4), 383-394. doi:10.1002/cjp2.272
2021
2020
Abstract A11: Screening the Ras proteome microenvironment using APEX2
Mo, S. P., Coulson, J. M., & Prior, I. A. (2020). Abstract A11: Screening the Ras proteome microenvironment using APEX2. Molecular Cancer Research, 18(5_Supplement), A11. doi:10.1158/1557-3125.ras18-a11
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo, C. R., Kalirai, H., Sacco, J. J., Azevedo, R. A., Duckworth, A., Slupsky, J. R., . . . Coupland, S. E. (2020). Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.. The Journal of Pathology, 250(4), 420-439. doi:10.1002/path.5384
2019
Targeting centrosome amplification, an Achilles' heel of cancer
Sabat-Pospiech, D., Fabian-Kolpanowicz, K., Prior, I. A., Coulson, J. M., & Fielding, A. B. (2019). Targeting centrosome amplification, an Achilles' heel of cancer. BIOCHEMICAL SOCIETY TRANSACTIONS, 47, 1209-1222. doi:10.1042/BST20190034
Isoform-specific Ras signaling is growth factor dependent
Hood, F. E., Klinger, B., Newlaczyl, A. U., Sieber, A., Dorel, M., Oliver, S. P., . . . Prior, I. A. (2019). Isoform-specific Ras signaling is growth factor dependent. Molecular biology of the cell, 30(9), 1108-1117. doi:10.1091/mbc.e18-10-0676
2018
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
Sheng, J., Zhao, Q., Zhao, J., Zhang, W., Sun, Y., Qin, P., . . . Wang, Y. (2018). SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance. EBioMedicine, 38, 113-126. doi:10.1016/j.ebiom.2018.11.007
RAS variant signalling
Mo, S. P., Coulson, J. M., & Prior, I. A. (2018). RAS variant signalling. BIOCHEMICAL SOCIETY TRANSACTIONS, 46, 1325-1332. doi:10.1042/BST20180173
Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma
Jama, N., Farquhar, N., Butt, Z., Coupland, S. E., Sacco, J. J., Scase, T., . . . Killick, D. R. (2018). Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma. Journal of Comparative Pathology, 162, 50-58. doi:10.1016/j.jcpa.2018.06.007
Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Sacco, J. J., Kalirai, H., Kenyani, J., Figueiredo, C. R., Coulson, J. M., & Coupland, S. E. (2018). Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?. FUTURE ONCOLOGY, 14(14), 1335-1338. doi:10.2217/fon-2018-0116
The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity
Fielding, A. B., Concannon, M., Darling, S., Rusilowicz, E., Sacco, J., Prior, I. A., . . . Coulson, J. M. (2018). The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity. Oncogene, 37(17), 2326-2342. doi:10.1038/s41388-017-0092-0
Kinome‐wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics
Bailey, F. P., Clarke, K., Kalirai, H., Kenyani, J., Shahidipour, H., Falciani, F., . . . Eyers, P. A. (2018). Kinome‐wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics. Pigment Cell and Melanoma Research, 31(2), 253-266. doi:10.1111/pcmr.12650
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
Wilson, L. J., Linley, A., Hammond, D. E., Hood, F. E., Coulson, J. M., MacEwan, D. J., . . . Prior, I. A. (2018). New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome. CANCER RESEARCH, 78(1), 15-29. doi:10.1158/0008-5472.CAN-17-2291
Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
Farquhar, N., Thornton, S., Coupland, S. E., Coulson, J., Sacco, J. J., Krishna, Y., . . . Kalirai, H. (2018). Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. The Journal of Pathology: Clinical Research, 4(1), 26-38. doi:10.1002/cjp2.86
2017
Regulation of the cell cycle and centrosome biology by deubiquitylases
Darling, S., Fielding, A. B., Sabat-Pospiech, D., Prior, I. A., & Coulson, J. M. (2017). Regulation of the cell cycle and centrosome biology by deubiquitylases. BIOCHEMICAL SOCIETY TRANSACTIONS, 45, 1125-1136. doi:10.1042/BST20170087
Quantification of spatiotemporal patterns of Ras isoform expression during development
Newlaczyl, A. U., Coulson, J. M., & Prior, I. A. (2017). Quantification of spatiotemporal patterns of Ras isoform expression during development. Scientific reports, 7. doi:10.1038/srep41297
Transcriptomic and Epigenetic Regulation of Disuse Atrophy and the Return to Activity in Skeletal Muscle
Fisher, A. G., Seaborne, R. A., Hughes, T. M., Gutteridge, A., Stewart, C., Coulson, J. M., . . . Jarvis, J. (2017). Transcriptomic and Epigenetic Regulation of Disuse Atrophy and the Return to Activity in Skeletal Muscle. The FASEB Journal, 31(12), 5268-5282. doi:10.1096/fj.201700089RR
2016
BAP1-deficient mesothelioma: identifying mechanisms for response to HDAC inhibitors and screening for novel drug sensitivities
Butt, Z., Kenyani, J., Sacco, J., & Coulson, J. (2016). BAP1-deficient mesothelioma: identifying mechanisms for response to HDAC inhibitors and screening for novel drug sensitivities. In EUROPEAN JOURNAL OF CANCER Vol. 61 (pp. S180-S181). doi:10.1016/S0959-8049(16)61640-4
Transcription Factors Regulating Neuroendocrine Development, Function, and Oncogenesis
Coulson, J. M., & Concannon, M. (2016). Transcription Factors Regulating Neuroendocrine Development, Function, and Oncogenesis. In Unknown Book (pp. 97-120). Wiley. doi:10.1002/9781118760369.ch5
2015
Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells
Malec, V., Coulson, J. M., Urbe, S., & Clague, M. J. (2015). Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells. JOURNAL OF PROTEOME RESEARCH, 14(12), 5263-5272. doi:10.1021/acs.jproteome.5b00692
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors
Sacco, J., Kenyani, J., Butt, Z., Carter, R., Chew, H. Y., Cheeseman, L. P., . . . Coulson, J. (2015). Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors. Oncotarget, 6(15), 13757-13771. doi:10.18632/oncotarget.3765
2014
Plasticity of Mammary Cell Boundaries Governed by EGF and Actin Remodeling
Tang, W. Y., Beckett, A., Prior, I., Coulson, J., Urbe, S., & Clague, M. (2014). Plasticity of Mammary Cell Boundaries Governed by EGF and Actin Remodeling. Cell Reports, 8(06), 1722-1730. doi:10.1016/j.celrep.2014.08.026
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
Sacco, J., Yau, T. Y., Darling, S., Patel, V., Liu, H., Urbe, S., . . . Coulson, J. (2014). The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells. Oncogene, 33(33), 4265-4272. doi:10.1038/onc.2013.512
Decoding RAS isoform and codon-specific signalling
Newlaczyl, A. U., Hood, F. E., Coulson, J. M., & Prior, I. A. (2014). Decoding RAS isoform and codon-specific signalling. BIOCHEMICAL SOCIETY TRANSACTIONS, 42, 742-746. doi:10.1042/BST20140057
2013
Deubiquitylases From Genes to Organism
Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., & Urbé, S. (2013). Deubiquitylases From Genes to Organism. Physiological Reviews, 93(3), 1289-1315. doi:10.1152/physrev.00002.2013
The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit
Faronato, M., Patel, V., Darling, S., Dearden, L., Clague, M. J., Urbe, S., & Coulson, J. M. (2013). The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit. CELL CYCLE, 12(12), 1964-1977. doi:10.4161/cc.25035
2012
Direct and Indirect Control of Mitogen-activated Protein Kinase Pathway-associated Components, BRAP/IMP E3 Ubiquitin Ligase and CRAF/RAF1 Kinase, by the Deubiquitylating Enzyme USP15
Hayes, S. D., Liu, H., MacDonald, E., Sanderson, C. M., Coulson, J. M., Clague, M. J., & Urbe, S. (2012). Direct and Indirect Control of Mitogen-activated Protein Kinase Pathway-associated Components, BRAP/IMP E3 Ubiquitin Ligase and CRAF/RAF1 Kinase, by the Deubiquitylating Enzyme USP15. JOURNAL OF BIOLOGICAL CHEMISTRY, 287(51), 43007-43018. doi:10.1074/jbc.M112.386938
Cellular functions of the DUBs
Clague, M. J., Coulson, J. M., & Urbe, S. (2012). Cellular functions of the DUBs. JOURNAL OF CELL SCIENCE, 125(2), 277-286. doi:10.1242/jcs.090985
2011
Isoform‐Specific Localization of the Deubiquitinase USP33 to the Golgi Apparatus
Thorne, C., Eccles, R. L., Coulson, J. M., Urbé, S., & Clague, M. J. (2011). Isoform‐Specific Localization of the Deubiquitinase USP33 to the Golgi Apparatus. Traffic, 12(11), 1563-1574. doi:10.1111/j.1600-0854.2011.01261.x
REST (RE1-silencing transcription factor)
Faronato, M., & Coulson, J. M. (n.d.). REST (RE1-silencing transcription factor). Atlas of Genetics and Cytogenetics in Oncology and Haematology, (2). doi:10.4267/2042/44968
USP15 (ubiquitin specific peptidase 15)
Faronato, M., Urbé, S., & Coulson, J. M. (n.d.). USP15 (ubiquitin specific peptidase 15). Atlas of Genetics and Cytogenetics in Oncology and Haematology, (8). doi:10.4267/2042/46013
2010
Emerging roles of deubiquitinases in cancer‐associated pathways
Sacco, J. J., Coulson, J. M., Clague, M. J., & Urbé, S. (2010). Emerging roles of deubiquitinases in cancer‐associated pathways. IUBMB Life, 62(2), 140-157. doi:10.1002/iub.300
2009
Reduction in RNA Levels Rather than Retardation of Translation Is Responsible for the Inhibition of Major Histocompatibility Complex Class I Antigen Presentation by the Glutamic Acid-Rich Repeat of Herpesvirus Saimiri Open Reading Frame 73
Gao, J., Coulson, J. M., Whitehouse, A., & Blake, N. (2009). Reduction in RNA Levels Rather than Retardation of Translation Is Responsible for the Inhibition of Major Histocompatibility Complex Class I Antigen Presentation by the Glutamic Acid-Rich Repeat of Herpesvirus Saimiri Open Reading Frame 73. JOURNAL OF VIROLOGY, 83(1), 273-282. doi:10.1128/JVI.01532-08
SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer
Moss, A. C., Jacobson, G. M., Walker, L. E., Blake, N. W., Marshall, E., & Coulson, J. M. (2009). SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer. CLINICAL CANCER RESEARCH, 15(1), 274-283. doi:10.1158/1078-0432.CCR-08-1163
2008
Deciphering histone 2A deubiquitination
Clague, M. J., Coulson, J. M., & Urbe, S. (2008). Deciphering histone 2A deubiquitination. GENOME BIOLOGY, 9(1). doi:10.1186/gb-2008-9-1-202
Real-time polymerase chain reaction to follow the response of muscle to training
Moore, L. M., Fisher, A. G., Coulson, J. M., Salmons, S., & Jarvis, J. C. (2008). Real-time polymerase chain reaction to follow the response of muscle to training. ARTIFICIAL ORGANS, 32(8), 630-633. doi:10.1111/j.1525-1594.2008.00613.x
2007
Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER
Aladin, F., Lautscham, G., Humphries, E., Coulson, J., & Blake, N. (2007). Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER. CANCER IMMUNOLOGY IMMUNOTHERAPY, 56(8), 1143-1152. doi:10.1007/s00262-006-0263-2
2006
Site-specific phosphorylation of SCG10 in neuronal plasticity:: Role of Ser73 phosphorylation by <i>N</i>-methyl D-aspartic acid receptor activation in rat hippocampus
Morii, H., Yamada, T., Nakano, I., Coulson, J. M., & Mori, N. (2006). Site-specific phosphorylation of SCG10 in neuronal plasticity:: Role of Ser73 phosphorylation by <i>N</i>-methyl D-aspartic acid receptor activation in rat hippocampus. NEUROSCIENCE LETTERS, 396(3), 241-246. doi:10.1016/j.neulet.2005.11.043
Regulation and role of REST and REST4 variants in modulation of gene expression in <i>in vivo</i> and <i>in vitro</i> in epilepsy models
Spencer, E. M., Chandler, K. E., Haddley, K., Howard, M. R., Hughes, D., Belyaev, N. D., . . . Quinn, J. P. (2006). Regulation and role of REST and REST4 variants in modulation of gene expression in <i>in vivo</i> and <i>in vitro</i> in epilepsy models. NEUROBIOLOGY OF DISEASE, 24(1), 41-52. doi:10.1016/j.nbd.2006.04.020
2005
Transcriptional regulation: Cancer, neurons and the REST
Coulson, J. M. (2005). Transcriptional regulation: Cancer, neurons and the REST. CURRENT BIOLOGY, 15(17), R665-R668. doi:10.1016/j.cub.2005.08.032
P-003 Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis
Baokbah, T., Ocejo-Garcia, M., Ashurst, L., Cowlishaw, D., Soomro, I., Coulson, J., & Woll, P. (2005). P-003 Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. Lung Cancer, 49, S115. doi:10.1016/s0169-5002(05)80497-0
P-006 Regulation of USF transcription factors by nucleocytoplasmic shuttling and post-translational modification in lung tumors
Bennett, E., Baokbah, T., & Coulson, J. (2005). P-006 Regulation of USF transcription factors by nucleocytoplasmic shuttling and post-translational modification in lung tumors. Lung Cancer, 49, S116. doi:10.1016/s0169-5002(05)80500-8
P-091 Targeting small cell lung cancer with virus-specific CD8+cytotoxic t lymphocytes
Moss, A., Aladin, F., Marshal, E., Blake, N., & Coulson, J. (2005). P-091 Targeting small cell lung cancer with virus-specific CD8+cytotoxic t lymphocytes. Lung Cancer, 49, S137-S138. doi:10.1016/s0169-5002(05)80585-9
PD-001 Determining target genes of transcription factors in lung cancerby proteome and transcriptome analysis
Baokbah, T., Jacobson, G., Hamlett, J., Wareing, B., Russo, A., & Coulson, J. (2005). PD-001 Determining target genes of transcription factors in lung cancerby proteome and transcriptome analysis. Lung Cancer, 49, S67. doi:10.1016/s0169-5002(05)80333-2
Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis
Ocejo-Garcia, M., Baokbah, T. A. S., Ashurst, H. L., Cowlishaw, D., Soomro, I., Coulson, J. M., & Woll, P. J. (2005). Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. JOURNAL OF PATHOLOGY, 206(2), 151-159. doi:10.1002/path.1775
2004
Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein
Viney, T. J., Schmidt, T. W., Gierasch, W., Sattar, A. W., Yaggie, R. E., Kuburas, A., . . . Russo, A. F. (2004). Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. JOURNAL OF BIOLOGICAL CHEMISTRY, 279(48), 49948-49955. doi:10.1074/jbc.M406659200
Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases
Khan, S., Coulson, J. M., & Woll, P. J. (2004). Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases. INTERNATIONAL JOURNAL OF CANCER, 110(6), 891-895. doi:10.1002/ijc.20156
Overexpression of cyclooxygenase-2 in non-small cell lung cancer
Petkova, D. K., Clelland, C., Ronan, J., Pang, L., Coulson, J. M., Lewis, S., & Knox, A. J. (2004). Overexpression of cyclooxygenase-2 in non-small cell lung cancer. RESPIRATORY MEDICINE, 98(2), 164-172. doi:10.1016/j.rmed.2003.09.006
2003
P-124 Regulation of gene expression in lung cancer by neuron restrictive silencer factor isoforms
Coulson, J. M., Chen, J., Baokbah, T., Eccleston, C., Woll, P. J., & Quinn, J. P. (2003). P-124 Regulation of gene expression in lung cancer by neuron restrictive silencer factor isoforms. Lung Cancer, 41, S122. doi:10.1016/s0169-5002(03)92093-9
Cross-talk between hypoxic and circadian pathways:: cooperative roles for hypoxia-inducible factor 1α and CLOCK in transcriptional activation of the vasopressin gene
Ghorbel, M. T., Coulson, J. M., & Murphy, D. (2003). Cross-talk between hypoxic and circadian pathways:: cooperative roles for hypoxia-inducible factor 1α and CLOCK in transcriptional activation of the vasopressin gene. MOLECULAR AND CELLULAR NEUROSCIENCE, 22(3), 396-404. doi:10.1016/S1044-7431(02)00019-2
Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box
Coulson, J. M., Edgson, J. L., Marshal-Jones, Z. V., Mulgrew, R., Quinn, J. P., & Woll, P. J. (2003). Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box. BIOCHEMICAL JOURNAL, 369, 549-561. doi:10.1042/BJ20021176
Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor.
Coulson, J. M., Ahmed, S. I., Quinn, J. P., & Woll, P. J. (2003). Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor.. Methods in molecular medicine, 75, 335-352. doi:10.1385/1-59259-324-0:335
Neuroendocrine phenotype of small cell lung cancer.
Coulson, J. M., Ocejo-Garcia, M., & Woll, P. J. (2003). Neuroendocrine phenotype of small cell lung cancer.. In Unknown Book (Vol. 74, pp. 61-73). doi:10.1385/1-59259-323-2:61
2002
Neuron restrictive silencer factor as a modulator of neuropeptide gene expression
Quinn, J. P., Bubb, V. J., Marshall-Jones, Z. V., & Coulson, J. M. (2002). Neuron restrictive silencer factor as a modulator of neuropeptide gene expression. REGULATORY PEPTIDES, 108(2-3), 135-141. doi:10.1016/S0167-0115(02)00103-9
Genetic and Epigenetic Changes in Plasma Dna of Lung Cancer Patients
Khan, S., Coulson, J., & Woll, P. J. (2002). Genetic and Epigenetic Changes in Plasma Dna of Lung Cancer Patients. Clinical Science, 103(s47), 48P. doi:10.1042/cs103048pa
Chapter 26 Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer
Coulson, J. M. (2002). Chapter 26 Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer. In Progress in Brain Research (pp. 329-343). Elsevier. doi:10.1016/s0079-6123(02)39028-9
Neuron restrictive silencer factor as a modulator of neuropeptide gene expression.
Quinn, J. P., Bubb, V. J., Marshall-Jones, Z. V., & Coulson, J. M. (2002). Neuron restrictive silencer factor as a modulator of neuropeptide gene expression.. Regulatory Peptides, 108(2-3), 1-9.
Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer
Coulson, J. M. (2002). Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer. In Unknown Book (Vol. 139, pp. 329-343). Retrieved from https://www.webofscience.com/
2001
Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer
Ocejo-Garcia, M., Ahmed, S. I., Coulson, J. M., & Woll, P. J. (2001). Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer. LUNG CANCER, 33(1), 1-9. doi:10.1016/S0169-5002(00)00248-8
2000
Characterisation and exploitation of a novel neuron-restrictive silencer factor isoform in neuroendocrine small cell lung cancer
Coulson, J. M., Edgson, J. L., Quinn, J. P., & Woll, P. J. (2000). Characterisation and exploitation of a novel neuron-restrictive silencer factor isoform in neuroendocrine small cell lung cancer. Lung Cancer, 29(1), 190. doi:10.1016/s0169-5002(00)80640-6
RT-PCR detection of neuropeptides and their receptors in small cell lung cancer (SCLC) is a sensitive method of detecting minimal disease
Woll, P. J., Ahmed, S. I., Ocejo-Garcia, M., & Coulson, J. M. (2000). RT-PCR detection of neuropeptides and their receptors in small cell lung cancer (SCLC) is a sensitive method of detecting minimal disease. Lung Cancer, 29(1), 254. doi:10.1016/s0169-5002(00)80872-7
The role of upstream stimulatory factor in expression of the vasopressin gene in lung cancer
Coulson, J. M., Edgson, J. L., Mulgrew, R. J., Quinn, J. P., & Woll, P. J. (2000). The role of upstream stimulatory factor in expression of the vasopressin gene in lung cancer. Lung Cancer, 29(1), 204-205. doi:10.1016/s0169-5002(00)80699-6
A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker
Coulson, J. M., Edgson, J. L., Woll, P. J., & Quinn, J. P. (2000). A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker. CANCER RESEARCH, 60(7), 1840-1844. Retrieved from https://www.webofscience.com/
Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium
Ahmed, S. I., Thompson, J., Coulson, J. M., & Woll, P. J. (2000). Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 22(4), 422-431. doi:10.1165/ajrcmb.22.4.3795
1999
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer
Coulson, J. M., Fiskerstrand, C. E., Woll, P. J., & Quinn, J. P. (1999). E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer. BIOCHEMICAL JOURNAL, 344, 961-970. doi:10.1042/0264-6021:3440961
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer
COULSON, J. M., FISKERSTRAND, C. E., WOLL, P. J., & QUINN, J. P. (1999). E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer. Biochemical Journal, 344(3), 961-970. doi:10.1042/bj3440961
Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer
Coulson, J. M., Fiskerstrand, C. E., Woll, P. J., & Quinn, J. P. (1999). Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer. CANCER RESEARCH, 59(20), 5123-5127. Retrieved from https://www.webofscience.com/
Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
Coulson, J. M., Stanley, J., & Woll, P. J. (1999). Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer. BRITISH JOURNAL OF CANCER, 80(12), 1935-1944. doi:10.1038/sj.bjc.6690623
Arginine Vasopressin Promoter Regulation Is Mediated by a Neuron-restrictive Silencer Element in Small Cell Lung Cancer
Coulson, J. M., Fiskerstrand, C. E., Woll, P. J., & Quinn, J. P. (1999). Arginine Vasopressin Promoter Regulation Is Mediated by a Neuron-restrictive Silencer Element in Small Cell Lung Cancer. Cancer Research, (59), 5123-5127.
1997
A c-myc phosphorothioate oligonucleotide protects U87-MG glioblastoma cells from toxicity at high concentrations of lipofectin and streptolysin O
Coulson, J. M., & Akhtar, S. (1997). A c-myc phosphorothioate oligonucleotide protects U87-MG glioblastoma cells from toxicity at high concentrations of lipofectin and streptolysin O. Pharmaceutical Sciences, 3(4), 197-201.
1996
An oligonucleotide which blocks EGFr tyrosine phosphorylation modulates the rapid morphological change induced by EGF stimulation of A431 cells
Coulson, J. M., & Akhtar, S. (1996). An oligonucleotide which blocks EGFr tyrosine phosphorylation modulates the rapid morphological change induced by EGF stimulation of A431 cells. Pharmaceutical Sciences, 2(7), 339-343.
Erratum: An oligonucleotide which blocks EGFr tyrosine phosphorylation modulates the rapid morphological change induced by EGF stimulation of A431 cells (Pharmaceutical Sciences (1996) 2, 7 (339-343))
Coulson, J. M., & Akhtar, S. (1996). Erratum: An oligonucleotide which blocks EGFr tyrosine phosphorylation modulates the rapid morphological change induced by EGF stimulation of A431 cells (Pharmaceutical Sciences (1996) 2, 7 (339-343)). Pharmaceutical Sciences, 2(12), 605.
A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells
Coulson, J. M., Poyner, D. R., Chantry, A., Irwin, W. J., & Akhtar, S. (1996). A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells. MOLECULAR PHARMACOLOGY, 50(2), 314-325. Retrieved from https://www.webofscience.com/
1993
A novd method to stabilise antisense oUgonudeotides against exonudease degradation
Khan, I. M., & Coulson, J. M. (1993). A novd method to stabilise antisense oUgonudeotides against exonudease degradation. Nucleic Acids Research, 21(18), 4433. doi:10.1093/nar/21.18.4433
A novel method to stabilise antisense oligonucleotides against exonuclease degradation.
Khan, I. M., & Coulson, J. M. (1993). A novel method to stabilise antisense oligonucleotides against exonuclease degradation.. Nucleic acids research, 21(18), 4433. doi:10.1093/nar/21.18.4433
A NOVEL METHOD TO STABILIZE ANTISENSE OLIGONUCLEOTIDES AGAINST EXONUCLEASE DEGRADATION
KHAN, I. M., & COULSON, J. M. (1993). A NOVEL METHOD TO STABILIZE ANTISENSE OLIGONUCLEOTIDES AGAINST EXONUCLEASE DEGRADATION. NUCLEIC ACIDS RESEARCH, 21(12), 2957-2958. doi:10.1093/nar/21.12.2957
Erratum: A novel method to stabilise antisense oligonucleotides against exonuclease degradation (Nucleic Acids Research (1993) 21 (2957-2958))
Erratum: A novel method to stabilise antisense oligonucleotides against exonuclease degradation (Nucleic Acids Research (1993) 21 (2957-2958)) (1993). Nucleic Acids Research, 21(18), 4433.
1992
APPLICATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES IN VIROLOGY
MALCOLM, A. D. B., COULSON, J., BLAKE, N., & ARCHARD, L. C. (1992). APPLICATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES IN VIROLOGY. In BIOCHEMICAL SOCIETY TRANSACTIONS Vol. 20 (pp. 762-764). doi:10.1042/bst0200762
Antisense oligodeoxynucleotides as antiviral agents.
Coulson, J. M., Blake, N. W., Archard, L. C., & Malcolm, A. D. (1992). Antisense oligodeoxynucleotides as antiviral agents.. In Biochemical Society transactions Vol. 20 (pp. 321S). doi:10.1042/bst020321s
ANTISENSE OLIGONUCLEOTIDES AS ANTIVIRAL AGENTS
COULSON, J., & MALCOLM, A. D. B. (1992). ANTISENSE OLIGONUCLEOTIDES AS ANTIVIRAL AGENTS. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 660, 339-341. doi:10.1111/j.1749-6632.1992.tb21107.x
Antisense oligonucleotides as antiviral agents.
Coulson, J., & Malcolm, A. D. (1992). Antisense oligonucleotides as antiviral agents.. In Biochemical Society transactions Vol. 20 (pp. 213S). doi:10.1042/bst020213s
1991
The design of antisense oligonucleotides as antiviral agents
Coulson, J., & Malcolm, A. D. B. (1991). The design of antisense oligonucleotides as antiviral agents. In Journal of Pharmacy and Pharmacology, Supplement Vol. 43 (pp. 20).